danirixin



danirixin


SMILES Cc1c(F)cccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)[C@H]2CCCNC2)c1O
InChIKey NGYNBSHYFOFVLS-LBPRGKRZSA-N

Chemical Properties

Hydrogen bond acceptors 5
Hydrogen bond donors 4
Rotatable bonds 4
Molecular weight (Da) 441.1


No bioactivity data available.

danirixin


Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I
Phase II
Phase III
Phase IV


Compound is not listed as a drug.